Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00158132 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 199
- Enrollment target
NCT00158132: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT00158132 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 199 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00158132, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 199 participants
- Enrollment target
Study Summary
Cocaine addiction is a serious health problem with no available medical treatment for preventing relapse. Amantadine, a medication that improves muscle control, and propranolol, a medication that lowers blood pressure, may be useful in treating cocaine addiction in individuals with severe cocaine withdrawal symptoms. This study will evaluate the effectiveness of amantadine and propranolol in preventing drug relapse among cocaine addicts.
Interventions
- DRUG Placebo
- DRUG Propranolol
- DRUG Amantadine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 1999-09 |
| Est. Completion | 2006-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00158132
The ClinicalTrials.gov registry entry for NCT00158132 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 199 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00158132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00158132 about?
NCT00158132 is a clinical study titled "Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2". Cocaine addiction is a serious health problem with no available medical treatment for preventing relapse. Amantadine, a medication that improves muscle control, and propranolol, a medication that lowers blood pressure, may be useful in treating cocaine addiction in individuals with severe cocaine wi...
What is the current status of trial NCT00158132?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 199 participants. The study started on 1999-09. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00158132?
The interventions under investigation include: Placebo (DRUG), Propranolol (DRUG), Amantadine (DRUG).
Who is sponsoring clinical trial NCT00158132?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.